Argentina vs Benin: HIV/AIDS deaths averted by antiretroviral therapy
Argentina
4,021 deaths
in 2024
Benin
3,910 deaths
in 2024
Argentina rank
46th
Benin rank
47th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Argentina
- Benin
How they compare
Argentina currently reports 4,021 deaths against 3,910 deaths in Benin, a difference of 111 deaths.
The two have swapped places 3 times across 35 shared years of data; in 1990 it was Benin ahead.
Argentina ranks 46th and Benin ranks 47th of 157 countries.
Argentina has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Argentina | Benin | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 149.65 deaths | 0 deaths | 149.65 deaths | Argentina |
| 2000s | 2,595 deaths | 514.49 deaths | 2,080 deaths | Argentina |
| 2010s | 3,781 deaths | 3,602 deaths | 178.75 deaths | Argentina |
| 2020s | 4,018 deaths | 3,905 deaths | 113.09 deaths | Argentina |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Argentina or Benin?
- Argentina, at 4,021 deaths against 3,910 deaths in Benin as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Argentina and Benin?
- 111 deaths, with Argentina ahead.
- How many years of comparable data are there for Argentina and Benin?
- 35 years are reported by both, from 1990 to 2024.
- How do Argentina and Benin rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Argentina ranks 46th and Benin ranks 47th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.